VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NVX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
NVXNovonix Limited
$0.44$66M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksNVXBalance Sheet

Novonix Limited (NVX) Balance Sheet

12Y historyFree accessUpdated daily

Financial leverage has increased significantly, with total debt rising to $99.3M by 2025Q4, while net PPE now accounts for $180.5M of the company's $282.8M in total assets.

NVX Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricDec'25Dec'24Dec'23Dec'22Jun'22Jun'21Jun'20Jun'19Jun'18Jun'17Jun'16Jun'15
Total Current Assets89.13M57.3M89.15M116.15M162.22M144.03M41.4M7.85M1.85M3.11M1.7M6.42K
Cash & Short-Term Investments84.12M42.56M78.63M99.04M142.74M136.66M38.81M6.05M396.22K2.42M1.67M10
Cash Only84.12M42.56M78.71M99.04M142.74M136.66M38.81M6.05M396.22K2.42M1.67M10
Short-Term Investments00702.87K000000000
Accounts Receivable2.12M8.16M3.56M2.85M2.45M2.04M1.23M478.4K595.91K289.99K38.76K6.41K
Days Sales Outstanding137.41508.63161.52277.38146.72142.65108.4896.1100.151.31K700.61-
Inventory2.18M1.38M2M3.17M1.87M2.78M1.37M1.12M646.14K318.69K00
Days Inventory Outstanding26.58285.3259.2247.51396.23119.32412.57122.0585.1882.75--
Other Current Assets33.5M3.34M9.14M10.09M2.27M0204.71K215.3K88.34K00
Total Non-Current Assets193.7M168.8M174.19M161.28M140.76M58.83M33.85M27.07M35.2M32.39M1.22M100.75K
Property, Plant & Equipment180.48M155.67M144.28M89M111.56M38.99M12.47M5.98M2.44M12.81M16.96K0
Fixed Asset Turnover0.03x0.04x0.06x0.04x0.05x0.13x0.33x0.30x0.89x0.01x1.19x-
Goodwill11.97M11.98M11.98M8.18M11.98M15.95M17.41M17.04M4.55M4.42M00
Intangible Assets0010.41K8.32M389.75K16.58M18.37M18.23M5.03M531.27K00
Long-Term Investments0016.63M11.27M16.67M007.67M11.64M13.09M00
Other Non-Current Assets1.24M1.16M1.25M52.69M168.71K-12.69M-14.4M-21.86M8.71M12.5K1.2M100.75K
Total Assets282.83M226.1M263.34M277.42M302.98M202.86M75.26M34.92M37.05M35.5M2.92M107.17K
Asset Turnover0.02x0.03x0.03x0.01x0.02x0.03x0.05x0.05x0.06x0.00x0.01x-
Asset Growth %25.09%-14.14%-5.08%-8.43%49.36%169.55%115.51%-5.76%4.38%1113.75%2629.08%-
Total Current Liabilities83.53M46.24M37.26M8.47M7.89M5.35M3.99M6.13M973.03K13.13M211.93K111.1K
Accounts Payable4.28M998.26K1.34M4.11M2.65M1.83M842.18K1.31M331.79K257.82K45.24K111.1K
Days Payables Outstanding52.06205.8173.9161.65561.2778.36254.18142.8943.7466.94--
Short-Term Debt61M30.64M28.73M114.16K119.97K277.38K273.97K4.15M86.89K9.22M00
Deferred Revenue (Current)146.43K126.06K418K71.98K2.71K310.1K000000
Other Current Liabilities17.06M6.76M1.75M3.69M896.08K2.53M2.73M677.5K554.35K3.66M166.69K0
Current Ratio1.07x1.24x2.39x13.72x20.56x26.90x10.38x1.28x1.90x0.24x8.04x0.06x
Quick Ratio1.04x1.21x2.34x13.35x20.32x26.38x10.04x1.10x1.24x0.21x8.04x0.06x
Cash Conversion Cycle111.93588.13246.83263.24-18.32183.6266.8775.26141.591.33K--
Total Non-Current Liabilities42.2M42.26M42.15M42.9M43.96M19.33M10.94M18.25M6.9M3.95M00
Long-Term Debt42.2M32.78M34.67M35.08M35.95M12.21M8.16M18.25M1.65M2.43M00
Capital Lease Obligations5.91M6.49M4.48M4.83M5.01M7.12M2.78M00000
Deferred Tax Liabilities000000002.83M1.52M00
Other Non-Current Liabilities-5.91M003M5.94K0000000
Total Liabilities125.73M88.51M79.41M51.37M51.85M24.68M14.94M24.38M7.87M17.08M211.93K111.1K
Total Debt99.27M70.42M68.22M40.37M41.41M20.01M11.35M22.39M1.73M11.64M00
Net Debt20.71M27.86M-10.49M-58.67M-101.32M-116.65M-27.46M16.34M1.34M9.23M-1.67M-10
Debt / Equity0.63x0.51x0.37x0.27x0.16x0.11x0.19x2.12x0.06x0.63x--
Debt / EBITDA-------61.60x----
Net Debt / EBITDA-------44.94x----
Interest Coverage-6.83x-20.00x-17.24x-30.31x-34.31x-93.07x-4.21x-10.54x-18.23x-9.46x--
Total Equity157.1M137.59M183.94M151.39M251.13M178.18M60.31M10.54M29.18M18.41M2.71M-3.93K
Equity Growth %14.18%-25.2%21.49%-39.72%40.95%195.42%472.02%-63.87%58.48%578.8%69163.77%-
Book Value per Share0.921.111.511.242.161.530.520.090.250.160.02-0.00
Total Shareholders' Equity157.1M137.59M183.94M151.39M251.13M178.18M60.31M10.54M29.18M18.41M2.71M-3.93K
Common Stock485.32M367.54M338.43M231.06M338.01M233.2M99.85M38.16M38.16M22.21M3.95M10
Retained Earnings-352.28M-259.67M-184.85M-94.72M-110.74M-81.93M-63.86M-43.83M-17.71M-7.38M-1.25M-3.94K
Treasury Stock000000000000
Accumulated OCI24.06M29.72M30.36M15.05M23.86M26.91M24.32M16.21M8.73M3.59M11.58K10
Minority Interest000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Capital intensive commercialization failure

Capital Erosion Amidst Scaling Efforts

As reported in recent financial filings, Novonix's equity base has faced significant pressure, declining from $251.1M in 2021Q4 to $157.1M by 2025Q4, a trend that highlights the persistent difficulty in balancing aggressive infrastructure investment with the ongoing operational losses inherent in its current pre-commercial manufacturing phase.

The trajectory of the balance sheet suggests a company increasingly reliant on external capital to bridge the gap between its technological ambitions and commercial reality. Investors should monitor whether the continued expansion of PPE can eventually be supported by internal cash generation, as the current trend indicates a steady depletion of shareholder equity.

Rising Leverage to Fund Operations

Based on the company's reported figures, total debt has climbed from $13.8M in 2021Q2 to $99.3M by 2025Q4, reflecting a strategic, albeit risky, reliance on debt financing to sustain the construction of the Riverside facility while the core business remains unable to generate positive operating cash flow.

The increase in the debt-to-equity ratio to 0.63 suggests that the company is leveraging its balance sheet to survive the long qualification cycles required by Tier-1 battery manufacturers. This debt burden warrants further investigation, as it introduces significant interest rate sensitivity and refinancing risk should the commercialization timeline face further delays.

Asset Concentration in Fixed Infrastructure

According to the latest balance sheet data, net PPE has surged to $180.5M in 2025Q4, representing the vast majority of the company's $282.8M in total assets, which underscores the highly capital-intensive nature of the business model and the significant risk of asset impairment if production targets are missed.

The heavy concentration in specialized manufacturing equipment implies that the company's value is almost entirely tied to the successful execution of its continuous furnace technology. If the facility fails to achieve nameplate capacity, the lack of asset liquidity could leave the company with limited options to recover its invested capital.

Tightening Liquidity Buffers and Runway

As indicated by the 2025Q4 current ratio of 1.07, Novonix's liquidity buffer has narrowed significantly from the high levels seen in previous years, suggesting that the company's cash runway is becoming increasingly constrained as it continues to burn through its remaining $84.1M in cash reserves.

The sharp decline in the current ratio from historical highs suggests that the company is operating with a much thinner margin of safety than in prior periods. This liquidity profile may force management to seek additional dilutive financing or government support, which could further impact the long-term value for existing shareholders.

NVX — Frequently Asked Questions

Quick answers to the most common questions about buying NVX stock.

What are the total assets of Novonix Limited (NVX)?

As of 2025, Novonix Limited (NVX) had total assets of $282.8M including $89.1M in current assets.

How much debt does Novonix Limited (NVX) have?

Novonix Limited (NVX) carries total debt of $99.3M, offset by $84.1M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Novonix Limited?

Novonix Limited (NVX) has total shareholders' equity (book value) of $157.1M ($0.92 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Novonix Limited's current ratio and liquidity?

Novonix Limited (NVX) reported a current ratio of 1.07x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.